Re: Zenith Updates

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Updates

posted on Feb 02, 2016 02:53PM

Google searches often turn up some unexpected tidbits. For example, I just found this blog entry on the Seton Hall University Department of Biology page discussing "BET Bromodomain Inhibition in Prostate Cancer Treatment" and highlighting ZEN-3694 and their upcoming trial.

Also, Zenith has updated their homepage and events page to reflect the H1 2016 anticipated start date and some spring events.